NEOMERCUROCROMO*SOL FL 50ML

NEOMERCUROCROMO cutaneous solution
Eosin/Chloroxylenol/Propylene Glycol

What it is and what it is used for
NEOMERCUROCROMO is a product based on eosin, chloroxylenol, and propylene glycol used for the local disinfectant treatment of superficial wounds, abrasions, superficial and non-extensive burns (first-degree burns), and minor pressure sores (i.e., affecting only the outermost layer of the skin).
Consult your doctor if you do not feel better or if you feel worse after a few days.

What you need to know before taking the medicine
Do not use NEOMERCUROCROMO

- if you are allergic to the active ingredients or any of the other ingredients of this medicine (listed in section 6).

Warnings and precautions
Consult your doctor or pharmacist before using Neomercurocromo.
• Do not use for prolonged treatments; after a short period of treatment without appreciable results, consult your doctor. The use, especially if prolonged, of products for cutaneous (local) use can lead to sensitization phenomena (excessive reaction of the body to foreign substances with which it has come into contact). In this case, discontinue treatment and consult your doctor to start an appropriate therapy.
• The product is for external use only.
• Accidental ingestion or inhalation of some disinfectants can have serious, sometimes fatal, consequences. In case of accidental ingestion, consult a doctor immediately.
• Avoid contact with eyes.
Neomercurocromo leaves stains on clothing that are difficult to remove.

Possible side effects
Like all medicines, this medicine can cause side effects, although not everybody gets them.

In some cases, burning or irritation (intolerance) may occur, which is without consequences and does not require a change in treatment. For repeated applications or following bandaging that does not allow the treated part to transpire, skin inflammations (eczematous reactions) may occur. The use of the medicine can lead to sun and UV sensitivity phenomena (photosensitization).
Following the instructions in the package leaflet reduces the risk of side effects.

Reporting of side effects
If you get any side effects, including any not listed in this leaflet, talk to your doctor or pharmacist. You can also report side effects directly via the national reporting system at: https://www.aifa.gov.it/content/segnalazionireazioni-avverse.
By reporting side effects, you can help provide more information on the safety of this medicine.